COVID-19 – Policy & Medicine

DEA Announces Extension of Telemedicine Flexibilities, Despite PHE Ending

PhRMA Submits Comments to USITC Regarding Section 332 Investigation

How Clinical Care Options Met Healthcare Professionals’ Needs in Real Time During the COVID-19 Pandemic

California Law Set to Regulate Dissemination of Misinformation Related to COVID-19

HHS OIG Finds that Certain Medicare Beneficiaries Took Greater Advantage of Telemedicine During Year 1 of the Pandemic

COVID Didn’t Seem to Slow Down FDA Drug Approvals

CMS Announces New Flexibilities to QPP and MIPS

The Great Resignation in Healthcare: Is it Coming?

COVID Tests Drove Increase in Medicare Part B Spending in 2020

MGMA and AHA Requested PHE Extension, Secretary Becerra Extends COVID-19 PHE